Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT03103971. IPD Sharing: NO. Countries: 1. Publications: 1.
Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response
ClinicalTrials.gov study NCT02126384. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma
ClinicalTrials.gov study NCT03110640. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Azacitidine and Rituximab-GDP Immunochemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03719989. IPD Sharing: NO. Countries: 1. Publications: 1.
PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
ClinicalTrials.gov study NCT00544219. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphoma
ClinicalTrials.gov study NCT01535989. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
ClinicalTrials.gov study NCT03984448. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer
ClinicalTrials.gov study NCT06139406. IPD Sharing: YES. Countries: 4. Publications: 0.
Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01334502. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors
ClinicalTrials.gov study NCT06735495. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis
ClinicalTrials.gov study NCT01951209. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04231747. IPD Sharing: YES. Countries: 2. Publications: 1.
CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
ClinicalTrials.gov study NCT06752785. IPD Sharing: NO. Countries: 1. Publications: 6.
Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05786989. IPD Sharing: NO. Countries: 1. Publications: 17.
CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT04690192. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Hutchison MediPharma Limited(HMPL)-523 in Patients With Relapsed or Refractory Mature B-cell Neoplasms
ClinicalTrials.gov study NCT02857998. IPD Sharing: NO. Countries: 1. Publications: 1.
Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01448096. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
ClinicalTrials.gov study NCT06764238. IPD Sharing: YES. Countries: 2. Publications: 10.
Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy
ClinicalTrials.gov study NCT00038571. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT01054781. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.